EU members split over AstraZeneca vaccine report
CGTN Europe • 2m 27s
Europe has once again failed to form a united front against the COVID-19 pandemic as a number of member states imposed age restrictions on the use of AstraZeneca's Vaxzevria vaccine, despite new guidance from the EU's drugs regulator that the shot should continue to be used across all age groups.
In total 17 member states now have restrictions in place in a move that risks confusing citizens, undermining confidence, and further delaying the bloc's already sluggish immunization program.
On Thursday, Germany said it would stick to its national health regulator's recommendation to limit the jabs to people 60 years of age and over.
📲 Follow CGTN Europe on social media and other platforms👇🏼
https://stories.cgtneurope.tv/follow-cgtn-europe/index.html
Up Next in CGTN Europe
-
UK Deliveroo drivers strike for bette...
Hundreds of Deliveroo riders in cities across the UK have gone on strike to protest for increased pay and better conditions.
"We'll continue to pressure Deliveroo until they start to humanize the gig economy." said Alex Marshall from the Independent Workers Union of Great Britain.
"Other peopl...
-
EU drug regulator advises members to ...
💉The @EMA report on #AstraZeneca's vaccine has been met with mixed reactions across Europe.⚡️
The bloc's drug regulator is still recommending the vaccine for all age groups. But some countries have already limited its use to older generations only. 🇪🇺
Here’s what you need to know👇
https://new... -
The IMF forecasts strong economic rec...
As vaccine procurement slows down while case numbers rise, the IMF forecasts that although strong economic recovery is on the horizon, nations whose vaccination programs have been slow are less likely to do as well.
Read more: https://newseu.cgtn.com/news/2021-04-09/Private-consumption-behind-IM...
